2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on ES-SCLC: Does the Addition of Tremelimumab to Durvalumab + Chemo Provide Additional Benefit?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Ryan Gentzler
By 2020 ASCO Virtual Direct™ Highlights FEATURING Ryan Gentzler
175 views
August 4, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin
Lung
08:15
2020 ASCO Virtual Direct™ Highlights

2020 Update on Radiation Therapy in Lung Cancer: Is High-Dose Twice-…

Feat. H. Borghaei
10:59
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Targeted Therapy in NSCLC: Is Adjuvant Osimertin…

Feat. H. Borghaei
06:00
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Targeted Therapy in mNSCLC: Is Trastuzumab Derux…

Feat. R. Gentzler
03:50
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Lung Cancer Management During COVID-19: What Is …

Feat. R. Gentzler
12:36
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on IO in mNSCLC: Should We Still Consider Chemother…

Feat. R. Gentzler
08:41
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on ES-SCLC: Does the Addition of Tremelimumab to Du…

Feat. R. Gentzler